Tag

Drug Prices

All articles tagged with #drug prices

TrumpRx.gov aims to slash U.S. drug prices via MFN discounts
healthcare20 days ago

TrumpRx.gov aims to slash U.S. drug prices via MFN discounts

President Trump launched TrumpRx.gov to offer steep discounts on 40 high-cost medicines by tying U.S. prices to MFN prices paid in other developed nations. The rollout includes drugs from AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk, and Pfizer, with additional products to follow. Patients with prescriptions can access savings via printable or mobile coupons or through manufacturer channels integrated into TrumpRx.gov. Notable examples include large price cuts for diabetes, obesity, fertility, COPD, asthma, and insulin, such as Ozempic, Wegovy, Zepbound, Gonal-F, Cetrotide, Ovidrel, and insulin lispro. The move builds on prior executive orders and agreements aimed at lowering prices and reforming how American drug costs are set.

White House Unveils Great Healthcare Plan to Cut Costs and Increase Transparency
politics1 month ago

White House Unveils Great Healthcare Plan to Cut Costs and Increase Transparency

President Trump pitches the Great Healthcare Plan to Congress to lower drug prices via Most-Favored-Nation pricing, reduce insurance premiums by ending subsidy payments and funding cost-sharing reductions, curb PBM kickbacks, and boost price transparency with plain-English disclosures, posted costs, and expanded over-the-counter access, including direct payments to Americans.

Trump’s Great Healthcare Plan promises direct-to-consumer subsidies and sharper price cuts
politics1 month ago

Trump’s Great Healthcare Plan promises direct-to-consumer subsidies and sharper price cuts

President Trump unveils The Great Healthcare Plan, promising to lower costs by slashing prescription prices, reducing insurance premiums by redirecting subsidies to individuals, expanding funding for cost-sharing reductions, and enforcing price transparency from insurers and providers, including publishing prices and denial rates to empower consumers.

Big Pharma to Increase Prices on 350 Medications Despite Political Pressure
business1 month ago

Big Pharma to Increase Prices on 350 Medications Despite Political Pressure

Drugmakers plan to raise prices on at least 350 medicines in the U.S., including vaccines and cancer treatments, despite pressure from the Trump administration to lower costs, with some drugs also seeing significant price cuts. The increases are part of ongoing strategies to maximize profits amid regulatory and political scrutiny, while some companies adjust prices to keep pace with inflation and support innovation.

Big Pharma to Raise Prices on 350 Medications Despite Political Pressure
business1 month ago

Big Pharma to Raise Prices on 350 Medications Despite Political Pressure

Drugmakers plan to raise prices on at least 350 medicines in the US for 2026, including vaccines and cancer treatments, despite pressure from the Trump administration to lower costs. While some drugs will see price cuts, overall prices are increasing, with companies like Pfizer and GSK citing the need to support innovation and cover costs. These hikes occur even as the US continues to pay significantly more for prescription drugs compared to other developed nations.

Concerns Mount Over Trump's Impact on US Healthcare and Drug Prices
healthcare2 months ago

Concerns Mount Over Trump's Impact on US Healthcare and Drug Prices

The article argues that high drug prices in the US are primarily due to pharmaceutical companies charging what the market can bear, not foreign countries paying less, and criticizes Trump's approach of blaming international partners instead of addressing systemic issues within the US pharmaceutical industry and global trade policies that favor profits over access to medicines.

Trump Secures Drug Price Reductions with Major Pharma Companies
health2 months ago

Trump Secures Drug Price Reductions with Major Pharma Companies

President Trump announced agreements with nine pharmaceutical companies to lower drug prices in the U.S., including matching prices with other developed countries and offering new drugs at 'most-favored-nation' rates. The deal also involves donations of critical medicines and plans to launch a platform for direct drug purchases, aiming to improve drug affordability and health equity. The effectiveness of these measures will take years to fully assess.

Trump and Major Pharma Firms Agree to Lower Drug Prices
healthcare2 months ago

Trump and Major Pharma Firms Agree to Lower Drug Prices

Several major pharmaceutical companies, including Merck, Bristol Myers Squibb, and Gilead, have agreed to lower drug prices in the U.S. through voluntary deals with President Trump, which include offering certain medications at discounted rates and listing drugs on a new direct-to-consumer platform, in exchange for a temporary exemption from tariffs and commitments to invest in U.S. manufacturing.